83.86
前日終値:
$83.28
開ける:
$83.45
24時間の取引高:
83,595
Relative Volume:
0.02
時価総額:
$48.66B
収益:
$5.88B
当期純損益:
$1.34B
株価収益率:
35.70
EPS:
2.3489
ネットキャッシュフロー:
$799.60M
1週間 パフォーマンス:
-0.13%
1か月 パフォーマンス:
-0.25%
6か月 パフォーマンス:
+10.65%
1年 パフォーマンス:
+14.28%
Edwards Lifesciences Corp Stock (EW) Company Profile
名前
Edwards Lifesciences Corp
セクター
電話
(949) 250-2500
住所
ONE EDWARDS WAY, IRVINE, CA
EW を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
EW
Edwards Lifesciences Corp
|
83.84 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
|
ABT
Abbott Laboratories
|
120.89 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
91.92 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
349.61 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.18 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | アップグレード | Jefferies | Hold → Buy |
| 2025-10-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-10-07 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-07-29 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-04-24 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | アップグレード | Stifel | Hold → Buy |
| 2025-01-16 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-10-11 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-09-18 | ダウングレード | Jefferies | Buy → Hold |
| 2024-07-31 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-07-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-07-25 | ダウングレード | Truist | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-05-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-03-07 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-02-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-11-28 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-03-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | ダウングレード | Bernstein | Outperform → Underperform |
| 2023-01-30 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | ダウングレード | Stifel | Buy → Hold |
| 2022-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 開始されました | Mizuho | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-29 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 開始されました | Truist | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-03-16 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-27 | 繰り返されました | Citigroup | Buy |
| 2022-01-27 | 繰り返されました | Evercore ISI | Outperform |
| 2022-01-27 | 繰り返されました | Raymond James | Outperform |
| 2022-01-27 | 繰り返されました | Stifel | Buy |
| 2022-01-27 | 繰り返されました | UBS | Neutral |
| 2021-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-12-15 | アップグレード | Citigroup | Neutral → Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-12-06 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-07-30 | 繰り返されました | Deutsche Bank | Hold |
| 2021-07-30 | 繰り返されました | Jefferies | Buy |
| 2021-07-30 | 繰り返されました | Morgan Stanley | Overweight |
| 2021-07-30 | 繰り返されました | Oppenheimer | Outperform |
| 2021-07-30 | 繰り返されました | Stifel | Buy |
| 2021-07-30 | 繰り返されました | UBS | Neutral |
| 2021-07-30 | 繰り返されました | Wells Fargo | Equal Weight |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Neutral |
| 2021-04-05 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-11 | 繰り返されました | Canaccord Genuity | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Underperform |
| 2020-04-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Outperform |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-09-23 | 開始されました | Piper Jaffray | Overweight |
| 2019-07-24 | 繰り返されました | BofA/Merrill | Buy |
| 2019-03-18 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-01-18 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Hold |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-10-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | ダウングレード | Guggenheim | Buy → Neutral |
すべてを表示
Edwards Lifesciences Corp (EW) 最新ニュース
Scott Ullem Sells 7,700 Shares of Edwards Lifesciences (NYSE:EW) Stock - MarketBeat
Vega Investment Solutions Has $28,000 Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Purchased by Natixis - MarketBeat
Edwards Lifesciences Corporation $EW Shares Acquired by Ossiam - MarketBeat
Edwards Lifesciences’ Markowitz sells $50k in stock By Investing.com - Investing.com Canada
Edwards Lifesciences Corporation $EW Stock Position Increased by 2Xideas AG - MarketBeat
Edwards Lifesciences’ Markowitz sells $50k in stock - Investing.com
Barclays Raises Edwards Lifesciences (EW) Price Target to $103.0 - GuruFocus
Leerink Partners Adjusts Edwards Lifesciences PT to $87 From $88, Maintains Market Perform Rating - marketscreener.com
WINTON GROUP Ltd Acquires 43,197 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences stock price target raised to $95 from $90 at Bernstein - Investing.com
Invesco Ltd. Decreases Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Raised to $100.00 at Royal Bank Of Canada - MarketBeat
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says - MarketBeat
Epoch Investment Partners Inc. Has $20.45 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW): Stifel Raises Price Target to $100 | - GuruFocus
Edwards Lifesciences (EW) Sees Analyst Target Price Increase Tod - GuruFocus
Amundi Raises Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
UBS Maintains Neutral Rating on Edwards Lifesciences (EW) and Ra - GuruFocus
Will Edwards Lifesciences’ (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative? - Yahoo Finance
Edwards Lifesciences (EW) Analyst Rating Update for December 5, 2025 | EW Stock News - GuruFocus
Edwards Lifesciences (EW): Reassessing Valuation After Upbeat 2025–2026 Outlook and TAVR Growth Signals - Yahoo Finance
Edwards Lifesciences Sets Cautious Targets Yet Keeps Investors Interested - Finimize
Edwards Lifesciences : EW 2025 IC FINAL - marketscreener.com
Bernstein Adjusts Edwards Lifesciences Price Target to $95 From $90, Maintains Market Perform Rating - marketscreener.com
Wells Fargo Adjusts Price Target for Edwards Lifesciences (EW) | - GuruFocus
Edwards Lifesciences' Long-term Business Outlook Appears Achievable, RBC Says - marketscreener.com
Edwards Lifesciences Bags Prosthetic Valve Patent In EU - Law360
Truist Securities Raises Price Target for Edwards Lifesciences (EW) | EW Stock News - GuruFocus
How Do Investors Really Feel About Edwards Lifesciences Corp? - Benzinga
Edwards Lifesciences stock hits 52-week high at 87.42 USD By Investing.com - Investing.com Nigeria
Edwards Lifesciences stock hits 52-week high at 87.42 USD - Investing.com
Raymond James Adjusts PT on Edwards Lifesciences to $100 From $96, Maintains Outperform Rating - marketscreener.com
UBS Adjusts Price Target on Edwards Lifesciences to $92 From $90, Maintains Neutral Rating - marketscreener.com
Edwards Lifesciences price target raised to $92 from $90 at UBS - Investing.com
RBC Capital raises Edwards Lifesciences stock price target to $100 on 2026 outlook - Investing.com
Truist Securities Adjusts PT on Edwards Lifesciences to $92 From $90, Maintains Hold Rating - marketscreener.com
Edwards Lifesciences price target raised to $100 from $95 at Stifel - TipRanks
RBC Raises Price Target on Edwards Lifesciences to $100 From $95, Keeps Outperform Rating - marketscreener.com
Stifel Adjusts Price Target on Edwards Lifesciences to $100 From $95, Maintains Buy Rating - marketscreener.com
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $96 From $95, Maintains Overweight Rating - marketscreener.com
Barclays Adjusts Price Target on Edwards Lifesciences to $103 From $99, Maintains Overweight Rating - marketscreener.com
Canaccord Genuity Adjusts Price Target on Edwards Lifesciences to $89 From $84, Maintains Hold Rating - marketscreener.com
Edwards Lifesciences price target raised to $89 from $84 at Canaccord - TipRanks
Edwards Lifesciences stock price target raised to $92 from $90 at Truist - Investing.com Nigeria
Analyst BTIG Raises Price Target for Edwards Lifesciences (EW) t - GuruFocus
Edwards Lifesciences stock price target raised to $100 by Stifel - Investing.com South Africa
Edwards Lifesciences price target raised to $96 from $95 at Wells Fargo - TipRanks
Does Edwards Lifesciences’ Analyst Day Transcatheter Pipeline Update Reframe the Bull Case for EW? - simplywall.st
Edwards Lifesciences stock price target raised to $89 from $84 at Canaccord - Investing.com
Edwards Lifesciences Corp (EW) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):